270 related articles for article (PubMed ID: 28521362)
1. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL;
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362
[TBL] [Abstract][Full Text] [Related]
2. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.
Reiner AS; Sisti J; John EM; Lynch CF; Brooks JD; Mellemkjær L; Boice JD; Knight JA; Concannon P; Capanu M; Tischkowitz M; Robson M; Liang X; Woods M; Conti DV; Duggan D; Shore R; Stram DO; Thomas DC; Malone KE; Bernstein L; ; Bernstein JL
J Clin Oncol; 2018 May; 36(15):1513-1520. PubMed ID: 29620998
[TBL] [Abstract][Full Text] [Related]
4. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
Reding KW; Bernstein JL; Langholz BM; Bernstein L; Haile RW; Begg CB; Lynch CF; Concannon P; Borg A; Teraoka SN; Törngren T; Diep A; Xue S; Bertelsen L; Liang X; Reiner AS; Capanu M; Malone KE;
Breast Cancer Res Treat; 2010 Sep; 123(2):491-8. PubMed ID: 20135344
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide association study of contralateral breast cancer in the Women's Environmental Cancer and Radiation Epidemiology Study.
Sun X; Reiner AS; Tran AP; Watt GP; Oh JH; Mellemkjær L; Lynch CF; Knight JA; John EM; Malone KE; Liang X; Woods M; Derkach A; Concannon P; Bernstein JL; Shu X
Breast Cancer Res; 2024 Jan; 26(1):16. PubMed ID: 38263039
[TBL] [Abstract][Full Text] [Related]
8. Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population.
Brooks JD; Bernstein L; Teraoka SN; Knight JA; Mellemkjær L; John EM; Malone KE; Reiner AS; Lynch CF; Concannon P; Haile RW; Bernstein JL;
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2261-7. PubMed ID: 23033454
[TBL] [Abstract][Full Text] [Related]
9. Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.
Brooks JD; John EM; Mellemkjaer L; Lynch CF; Knight JA; Malone KE; Reiner AS; Bernstein L; Liang X; Shore RE; Stovall M; ; Bernstein JL
Cancer Med; 2016 Nov; 5(11):3282-3291. PubMed ID: 27700016
[TBL] [Abstract][Full Text] [Related]
10. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.
Brooks JD; Teraoka SN; Bernstein L; Mellemkjær L; Malone KE; Lynch CF; Haile RW; Concannon P; Reiner AS; Duggan DJ; Schiermeyer K; ; Bernstein JL; Figueiredo JC
Cancer Causes Control; 2013 Aug; 24(8):1605-14. PubMed ID: 23775025
[TBL] [Abstract][Full Text] [Related]
11. The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.
Knight JA; Blackmore KM; Fan J; Malone KE; John EM; Lynch CF; Vachon CM; Bernstein L; Brooks JD; Reiner AS; Liang X; Woods M; ; Bernstein JL
Breast Cancer Res; 2018 Mar; 20(1):23. PubMed ID: 29566728
[TBL] [Abstract][Full Text] [Related]
12. Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.
Mellemkjaer L; Dahl C; Olsen JH; Bertelsen L; Guldberg P; Christensen J; Børresen-Dale AL; Stovall M; Langholz B; Bernstein L; Lynch CF; Malone KE; Haile RW; Andersson M; Thomas DC; Concannon P; Capanu M; Boice JD; ; Bernstein JL
Br J Cancer; 2008 Feb; 98(4):728-33. PubMed ID: 18253122
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for contralateral breast cancer in Chennai (Madras), India.
Gajalakshmi CK; Shanta V; Hakama M
Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
[TBL] [Abstract][Full Text] [Related]
14. Reproductive history and risk of second primary breast cancer: the WECARE study.
Largent JA; Capanu M; Bernstein L; Langholz B; Mellemkaer L; Malone KE; Begg CB; Haile RW; Lynch CF; Anton-Culver H; Wolitzer A; Bernstein JL
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):906-11. PubMed ID: 17507614
[TBL] [Abstract][Full Text] [Related]
15. Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.
Knight JA; Fan J; Malone KE; John EM; Lynch CF; Langballe R; Bernstein L; Shore RE; Brooks JD; Reiner AS; Woods M; Liang X; Bernstein JL;
Int J Cancer; 2017 Sep; 141(5):916-924. PubMed ID: 28524234
[TBL] [Abstract][Full Text] [Related]
16. Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.
Brooks JD; Teraoka SN; Malone KE; Haile RW; Bernstein L; Lynch CF; Mellemkjær L; Duggan DJ; Reiner AS; Concannon P; Schiermeyer K; Lewinger JP; ; Bernstein JL; Figueiredo JC
Int J Mol Epidemiol Genet; 2013; 4(1):35-48. PubMed ID: 23565321
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Kramer I; Hooning MJ; Mavaddat N; Hauptmann M; Keeman R; Steyerberg EW; Giardiello D; Antoniou AC; Pharoah PDP; Canisius S; Abu-Ful Z; Andrulis IL; Anton-Culver H; Aronson KJ; Augustinsson A; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Brauch H; Bremer M; Brucker SY; Burwinkel B; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Choi JY; Clarke CL; ; Collée JM; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dos-Santos-Silva I; Dunning AM; Dwek M; Eccles DM; Evans DG; Fasching PA; Flyger H; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Giles GG; Goldgar DE; González-Neira A; Haiman CA; Håkansson N; Hamann U; Hartman M; Heemskerk-Gerritsen BAM; Hollestelle A; Hopper JL; Hou MF; Howell A; ; ; Ito H; Jakimovska M; Jakubowska A; Janni W; John EM; Jung A; Kang D; Kets CM; Khusnutdinova E; Ko YD; Kristensen VN; Kurian AW; Kwong A; Lambrechts D; Le Marchand L; Li J; Lindblom A; Lubiński J; Mannermaa A; Manoochehri M; Margolin S; Matsuo K; Mavroudis D; Meindl A; Milne RL; Mulligan AM; Muranen TA; Neuhausen SL; Nevanlinna H; Newman WG; Olshan AF; Olson JE; Olsson H; Park-Simon TW; Peto J; Petridis C; Plaseska-Karanfilska D; Presneau N; Pylkäs K; Radice P; Rennert G; Romero A; Roylance R; Saloustros E; Sawyer EJ; Schmutzler RK; Schwentner L; Scott C; See MH; Shah M; Shen CY; Shu XO; Siesling S; Slager S; Sohn C; Southey MC; Spinelli JJ; Stone J; Tapper WJ; Tengström M; Teo SH; Terry MB; Tollenaar RAEM; Tomlinson I; Troester MA; Vachon CM; van Ongeval C; van Veen EM; Winqvist R; Wolk A; Zheng W; Ziogas A; Easton DF; Hall P; Schmidt MK
Am J Hum Genet; 2020 Nov; 107(5):837-848. PubMed ID: 33022221
[TBL] [Abstract][Full Text] [Related]
18. A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.
Vachon CM; Schaid DJ; Ingle JN; Wickerham DL; Kubo M; Mushiroda T; Goetz MP; Carlson EE; Paik S; Wolmark N; Nakamura Y; Wang L; Weinshilboum R; Couch FJ
Breast Cancer Res Treat; 2015 Jan; 149(2):517-23. PubMed ID: 25575444
[TBL] [Abstract][Full Text] [Related]
19. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
20. Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Breast Cancer Res Treat; 2017 Nov; 166(1):145-156. PubMed ID: 28702891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
